Business Wire

RenaissanceRe Reports Net Income Available to Common Shareholders of $456.8 Million; Operating Income Available to Common Shareholders of $278.1 Million in the Second Quarter of 2021. Reports Strong Growth in Gross Premiums Written.

  • 27.6% annualized return on average common equity; 16.8% annualized operating return on average common equity.
  • 72.4% combined ratio; 48.0% current accident year net claims and claim expense ratio.
  • Continued strong top-line growth across both segments; 23.1% growth in gross premiums written; representing 38.1% growth in the Casualty and Specialty segment and 13.5% growth in the Property segment.
  • Repurchased $309.0 million of common shares in the second quarter; aggregate of $480.7 million of common shares repurchased in the first half of 2021; and an additional $137.5 million of common shares repurchased from July 1, 2021 through July 19, 2021.
  • Continued growth in the Capital Partners business, primarily driven by capital raises in Upsilon RFO and Medici, with Medici’s capital surpassing $1 billion.

PEMBROKE, Bermuda–(BUSINESS WIRE)–RenaissanceRe Holdings Ltd. (NYSE: RNR) (“RenaissanceRe” or the “Company”) today announced its financial results for the three months ended June 30, 2021.

Net Income Available to Common Shareholders per Diluted Common Share: $9.35

Operating Income Available to Common Shareholders per Diluted Common Share*: $5.64

Underwriting Income

$329.0M

Fee Income

$46.2M

Net Investment Income

$80.9M

Change in Book Value per Common Share: 6.3%

Change in Tangible Book Value per Common Share Plus Change in Accum. Dividends*: 6.7%

*

 

Annualized Operating Return on Average Common Equity, Operating Income Available to Common Shareholders, Operating Income Available to Common Shareholders per Diluted Common Share and Change in Tangible Book Value per Common Share Plus Change in Accumulated Dividends are non-GAAP financial measures; see “Comments on Regulation G” for a reconciliation of non-GAAP financial measures.

Kevin J. O’Donnell, President and Chief Executive Officer, said, “We delivered a solid quarter for our shareholders, characterized by strong underwriting growth, high quality fee income and robust investment returns. Our Casualty and Specialty team extended its leadership by continuing to find opportunities to support our customers and our Property segment deployed capital in attractive business at the mid-year renewals. I am pleased with the continued execution of our strategy and resulting growth in tangible book value per share, and remain confident in our ability to provide superior shareholder returns over the long term.”

Consolidated Financial Results – Second Quarter

 

Consolidated Highlights

 

 

 

 

 

Three months ended June 30

 

(in thousands, except per share amounts and percentages)

2021

 

2020

 

Gross premiums written

$

2,094,158

 

 

$

1,701,872

 

 

Underwriting income

 

328,976

 

 

 

217,137

 

 

Combined ratio

 

72.4

%

 

 

78.5

%

 

 

 

 

 

 

Net Income

 

 

 

 

Available to common shareholders

 

456,818

 

 

 

575,845

 

 

Available to common shareholders per diluted common share

$

9.35

 

 

$

12.63

 

 

Operating income (1)

 

 

 

 

Available to common shareholders

 

278,050

 

 

 

190,076

 

 

Available to common shareholders per diluted common share

$

5.64

 

 

$

4.06

 

 

Book value per common share

$

139.35

 

 

$

134.27

 

 

Change in book value per share

 

6.3

%

 

 

14.6

%

 

Tangible book value per common share plus accumulated dividends (1)

$

156.55

 

 

$

150.09

 

 

Change in tangible book value per common share plus change in accumulated dividends (1)

 

6.7

%

 

 

16.6

%

 

 

 

 

 

 

Return on average common equity – annualized

 

27.6

%

 

 

38.5

%

 

Operating return on average common equity – annualized (1)

 

16.8

%

 

 

12.7

%

(1)  

See “Comments on Regulation G” for a reconciliation of non-GAAP financial measures.

Three Drivers of Profit: Underwriting, Fee and Investment Income

Underwriting Results – Property Segment: Grew gross premiums written by 13.5%; combined ratio of 43.8%

 

Property Segment

 

 

 

 

 

 

 

 

Three months ended June 30

 

Q/Q

Change

 

(in thousands, except percentages)

2021

 

2020

 

 

Gross premiums written

$

1,183,556

 

$

1,042,536

 

13.5

%

 

Underwriting income

315,122

 

200,682

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting Ratios

 

 

 

 

 

 

 

Net claims and claim expense ratio – current accident year

26.4

  %

 

34.7

  %

 

(8.3

) pts

 

Net claims and claim expense ratio – prior accident years

(9.1

) %

 

(1.3

) %

 

(7.8

) pts

 

Net claims and claim expense ratio – calendar year

17.3

  %

 

33.4

  %

 

(16.1

) pts

 

Underwriting expense ratio

26.5

  %

 

25.7

  %

 

0.8

  pts

 

Combined ratio

43.8

  %

 

59.1

  %

 

(15.3

) pts

  • Gross premiums written increased 13.5%, driven by:

    Growth in the property catastrophe class of business of $49.5 million, or 7.0%, primarily driven by rate improvements, combined with increased shares on existing deals and new opportunities across underwriting platforms.

    Growth in the other property class of business of $91.5 million, or 27.7%, principally driven by rate improvements, which contributed to growth in new and existing business written in the current and prior periods across underwriting platforms, notably within catastrophe exposed U.S. property excess and surplus lines.

  • Ceded premiums written were $380.2 million, an increase of $41.8 million, or 12.4%. This increase was primarily driven by an increase in gross premiums written which were ceded to third-party investors in RenaissanceRe’s managed vehicles, principally RenaissanceRe Upsilon Fund Ltd.
  • Net claims and claim expense ratio decreased 16.1 percentage points, driven by lower current accident year net losses due to the relatively low level of catastrophe activity in the period and higher prior accident year net favorable development in the second quarter of 2021, compared to the second quarter of 2020. This decrease in the net claims and claim expense ratio resulted in a lower combined ratio in the second quarter of 2021, compared to the second quarter of 2020.
  • Underwriting income of $315.1 million, primarily driven by growth in net earned premiums as well as lower current accident year net incurred losses and higher prior accident year net favorable development.

Underwriting Results – Casualty and Specialty Segment: Grew gross premiums written by 38.1%

 

Casualty and Specialty Segment

 

 

 

 

 

 

 

 

Three months ended June 30

 

Q/Q

Change

 

(in thousands, except percentages)

2021

 

2020

 

 

Gross premiums written

$

910,602

 

$

659,336

 

38.1

%

 

Underwriting income

13,854

 

16,455

 

 

 

 

 

 

 

 

 

 

 

 

Underwriting Ratios

 

 

 

 

 

 

 

Net claims and claim expense ratio – current accident year

67.0

%

 

68.4

%

 

(1.4

) pts

 

Net claims and claim expense ratio – prior accident years

(0.1)

%

 

(1.7)

%

 

1.6

  pts

 

Net claims and claim expense ratio – calendar year

66.9

%

 

66.7

%

 

0.2

  pts

 

Underwriting expense ratio

30.9

%

 

30.1

%

 

0.8

  pts

 

Combined ratio

97.8

%

 

96.8

%

 

1.0

  pts

  • Gross premiums written increased 38.1%, primarily driven by growth in the general casualty, professional liability and other specialty lines of business. This growth was principally driven by increases in new and existing business written in the current and prior periods, combined with rate improvements.
  • Net claims and claim expense ratio was comparable to the second quarter of 2020, as the decrease in the current accident year net claims and claim expense ratio, which resulted from lower attritional losses, was offset by lower favorable prior accident year loss development in the second quarter of 2021.
  • The underwriting expense ratio increased 0.8 percentage points driven by an increase in the net acquisition expense ratio, principally due to the effects of purchase accounting amortization related to the acquisition of TMR, which favorably impacted the ratio in the second quarter of 2020, partially offset by improved operating leverage in the second quarter of 2021.

Fee Income: Continued growth in management fee income related to increased capital under management

 

Fee Income

 

 

 

 

 

 

 

Three months ended June 30

 

Q/Q

Change

 

(in thousands, except percentages)

2021

 

2020

 

 

Total management fee income

$

31,970

 

 

$

27,437

 

 

$

4,533

 

 

Total performance fee income (1)

14,187

 

 

18,073

 

 

(3,886

 

Total fee income

$

46,157

 

 

$

45,510

 

 

$

647

 

(1)

 

Performance fees are based on the performance of the individual vehicles or products, and may be negative in a particular period if, for example, large losses occur, which can potentially result in no performance fees or the reversal of previously accrued performance fees.

  • Total fee income increased by $0.6 million due to higher management fees related to increased capital under management compared to the second quarter of 2020. This was partially offset by lower performance fee income, primarily driven by the decrease in profit commissions resulting from underwriting losses from Winter Storm Uri in the first quarter of 2021.

Investment Results: Performance primarily driven by net realized and unrealized gains in fixed maturity and equity trading portfolios

 

Investment Results

 

 

 

 

 

 

 

Three months ended June 30

 

Q/Q

Change

 

(in thousands, except percentages)

2021

 

2020

 

 

Net investment income

$

80,925

 

$

89,305

 

$

(8,380)

 

Net realized and unrealized gains on investments

191,018

 

448,390

 

(257,372)

 

Total investment result

271,943

 

537,695

 

(265,752)

 

Total investment return – annualized

5.2

%

 

11.8

%

 

(6.6)

  pts

  • Total investment result decreased $265.8 million due to lower net realized and unrealized gains on investments in the second quarter of 2021 compared to the second quarter of 2020. The investment result in the second quarter of 2020 was favorably impacted by the market recovery following the disruption in global financial markets associated with the COVID-19 pandemic.

    The total investment result in the second quarter of 2021 was primarily driven by net realized and unrealized gains on investments of $191.0 million, principally within fixed maturity and equity investments, including:

Net realized and unrealized gains on fixed maturity investments, net of investments-related derivatives of $87.8 million, primarily as a result of decreasing yields on longer duration U.S. treasuries and a general decline in credit spreads.

Net realized and unrealized gains on equity investments, net of investments-related derivatives of $65.6 million, principally from realized and unrealized gains in the Company’s strategic investment portfolio.

Net realized and unrealized gains on other investments of $37.6 million, principally from fund investments as a result of fair value appreciation of the underlying investments.

  • Managed fixed maturity and short-term investment weighted average yield to maturity was 1.0% and average duration was 3.0 years on total consolidated fixed maturity and short-term investments, at fair value of $17.8 billion at June 30, 2021.

Other Items of Note

  • Net income attributable to redeemable noncontrolling interests was $113.5 million compared to $118.7 million in the second quarter of 2020, reflecting strong overall results across the Company’s consolidated joint ventures and managed funds in both periods.
  • Income tax expense of $13.9 million compared to $29.9 million in the second quarter of 2020. The income tax expense in both periods was principally driven by net realized and unrealized gains on investments, primarily in the Company’s U.S.-based operations, with significantly higher gains in the second quarter of 2020.
  • Raised capital totaling over $200 million in the second quarter of 2021 through RenaissanceRe Medici Fund Ltd. (“Medici”) and Upsilon RFO Re Ltd. (“Upsilon RFO”).
  • Raised gross proceeds of $500.0 million in July 2021 through the issuance of 20,000,000 Depositary Shares, each of which represents a 1/1,000th interest in a share of the Company’s 4.20% Series G Preference Shares, $1.00 par value and $25,000 liquidation preference per share (equivalent to $25.00 per Depositary Share). A portion of the proceeds from the issuance of the Series G Preference Shares will be used to redeem all of the outstanding 5.375% Series E Preference Shares, and the remaining net proceeds will be used for general corporate purposes.
  • Announced the redemption of all 11,000,000 outstanding 5.375% Series E Preference Shares in July 2021. The 5.375% Series E Preference Shares are anticipated to be redeemed on August 11, 2021 for $275.0 million plus accrued and unpaid dividends thereon. Following the redemption, no 5.375% Series E Preference Shares will remain outstanding.

RenaissanceRe continues to monitor COVID-19 and expects that there may be significant industry losses

  • RenaissanceRe continues to evaluate industry trends and potential exposure associated with the ongoing COVID-19 pandemic, and expects historically significant industry losses to emerge over time as the full impact of the pandemic and its effects on the global economy are realized. Net claims and claim expenses incurred associated with the COVID-19 pandemic were not significant in the second quarter of 2021.
  • RenaissanceRe continues to actively monitor information received from or reported by clients, brokers, industry actuaries, regulators, courts, and others, and to assess that information in the context of its own portfolio. Loss estimates represent RenaissanceRe’s best estimate based on currently available information, and actual losses may vary materially from these estimates.

     

Conference Call Details and Additional Information

Non-GAAP Financial Measures and Additional Financial Information

This Press Release includes certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. (“GAAP”) including “operating income (loss) available (attributable) to RenaissanceRe common shareholders,” “operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share – diluted,” “operating return on average common equity – annualized,” “tangible book value per common share” and “tangible book value per common share plus accumulated dividends.” A reconciliation of such measures to the most comparable GAAP figures in accordance with Regulation G is presented in the attached supplemental financial data.

Please refer to the “Investors – Financial Reports – Financial Supplements” section of the Company’s website at www.renre.com for a copy of the Financial Supplement which includes additional information on the Company’s financial performance.

Conference Call Information

RenaissanceRe will host a conference call on Friday, July 23, 2021 at 10:00 a.m. ET to discuss this release. Live broadcast of the conference call will be available through the “Investors – Webcasts & Presentations” section of the Company’s website at www.renre.com.

About RenaissanceRe

RenaissanceRe is a global provider of reinsurance and insurance that specializes in matching well-structured risks with efficient sources of capital. The Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. Established in 1993, RenaissanceRe has offices in Bermuda, Australia, Ireland, Singapore, Switzerland, the United Kingdom and the United States.

Cautionary Statement Regarding Forward-Looking Statements

Any forward-looking statements made in this Press Release reflect RenaissanceRe’s current views with respect to future events and financial performance and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are subject to numerous factors that could cause actual results to differ materially from those set forth in or implied by such forward-looking statements, including the following: the uncertainty of the continuing and future impact of the COVID-19 pandemic, including measures taken in response thereto and the effect of legislative, regulatory and judicial influences on the Company’s financial performance and the Company’s ability to conduct its business; the frequency and severity of catastrophic and other events the Company covers; the effectiveness of the Company’s claims and claim expense reserving process; the effect of climate change on the Company’s business, including the trend towards increasingly frequent and severe climate events; the Company’s ability to maintain its financial strength ratings; the effect of emerging claims and coverage issues; collection on claimed retrocessional coverage, and new retrocessional reinsurance being available on acceptable terms and providing the coverage that the Company intended to obtain; the highly competitive nature of the Company’s industry, resulting in consolidation of competitors, customers and insurance and reinsurance brokers, and the Company’s reliance on a small and decreasing number of brokers for the preponderance of its revenue; the Company’s exposure to credit loss from counterparties in the normal course of business; the effect of continued challenging economic conditions throughout the world; the performance of the Company’s investment portfolio and financial market volatility; a contention by the U.S. Internal Revenue Service that Renaissance Reinsurance Ltd. or any of the Company’s other Bermuda subsidiaries is subject to taxation in the U.S.; the effects of U.S. tax reform legislation, Organization for Economic Co-operation and Development or European Union (“EU”) measures and possible future tax reform legislation and regulations, including changes to the tax treatment of the Company’s shareholders or investors in its joint ventures or other entities the Company manages; the effect of cybersecurity risks, including technology breaches or failure, on the Company’s business; the Company’s ability to successfully implement its business strategies and initiatives, and the success of any of the Company’s strategic investments or acquisitions, including its ability to manage its operations as its product and geographical diversity increases; the Company’s ability to retain its key senior officers and to attract or retain the executives and employees necessary to manage its business; the Company’s ability to effectively manage capital on behalf of investors in joint ventures or other entities it manages; foreign currency exchange rate fluctuations; soft reinsurance underwriting market conditions; changes in the method for determining the London Inter-bank Offered Rate (“LIBOR”) and the replacement of LIBOR; losses the Company could face from terrorism, political unrest or war; the Company’s ability to determine any impairments taken on its investments; the effects of inflation; the ability of the Company’s ceding companies and delegated authority counterparties to accurately assess the risks they underwrite; the effect of operational risks, including system or human failures; the Company’s ability to raise capital if necessary; the Company’s ability to comply with covenants in its debt agreements; changes to the accounting rules and regulatory systems applicable to the Company’s business, including changes in Bermuda laws or regulations or as a result of increased global regulation of the insurance and reinsurance industries; the Company’s dependence on the ability of its operating subsidiaries to declare and pay dividends; aspects of the Company’s corporate structure that may discourage third-party takeovers and other transactions; difficulties investors may have in serving process or enforcing judgments against the Company in the U.S.; the cyclical nature of the reinsurance and insurance industries; adverse legislative developments that reduce the size of the private markets the Company serves or impede their future growth and other political, regulatory or industry initiatives adversely impacting the Company; the Company’s ability to comply with applicable sanctions and foreign corrupt practices laws; international restrictions on the writing of reinsurance by foreign companies and government intervention in the natural catastrophe market; the Company’s need to make many estimates and judgments in the preparation of its financial statements; the effect of the exit by the United Kingdom from the EU; and other factors affecting future results disclosed in RenaissanceRe’s filings with the Securities and Exchange Commission, including its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and prospectus supplement dated July 7, 2021.

RenaissanceRe Holdings Ltd.

Summary Consolidated Statements of Operations

(in thousands of United States Dollars, except per share amounts and percentages)

(Unaudited)

 

Three months ended

 

Six months ended

 

June 30,
2021

 

June 30,
2020

 

June 30,
2021

 

June 30,
2020

Revenues

 

 

 

 

 

 

 

Gross premiums written

$

2,094,158

 

 

$

1,701,872

 

 

$

4,746,600

 

 

$

3,727,593

 

Net premiums written

$

1,512,292

 

 

$

1,180,803

 

 

$

3,336,375

 

 

$

2,450,611

 

Increase in unearned premiums

 

(319,502

)

 

 

(170,707

)

 

 

(989,749

)

 

 

(527,417

)

Net premiums earned

 

1,192,790

 

 

 

1,010,096

 

 

 

2,346,626

 

 

 

1,923,194

 

Net investment income

 

80,925

 

 

 

89,305

 

 

 

160,729

 

 

 

188,778

 

Net foreign exchange gains (losses)

 

3,234

 

 

 

(7,195

)

 

 

(19,554

)

 

 

(12,923

)

Equity in earnings of other ventures

 

8,732

 

 

 

9,041

 

 

 

3,174

 

 

 

13,605

 

Other income (loss)

 

586

 

 

 

(1,201

)

 

 

2,757

 

 

 

(5,637

)

Net realized and unrealized gains (losses) on investments

 

191,018

 

 

 

448,390

 

 

 

(154,545

)

 

 

337,683

 

Total revenues

 

1,477,285

 

 

 

1,548,436

 

 

 

2,339,187

 

 

 

2,444,700

 

Expenses

 

 

 

 

 

 

 

Net claims and claim expenses incurred

 

520,021

 

 

 

510,272

 

 

 

1,387,072

 

 

 

1,081,226

 

Acquisition expenses

 

285,590

 

 

 

233,610

 

 

 

552,824

 

 

 

444,214

 

Operational expenses

 

58,203

 

 

 

49,077

 

 

 

113,514

 

 

 

116,538

 

Corporate expenses

 

10,125

 

 

 

11,898

 

 

 

20,530

 

 

 

27,889

 

Interest expense

 

11,833

 

 

 

11,842

 

 

 

23,745

 

 

 

26,769

 

Total expenses

 

885,772

 

 

 

816,699

 

 

 

2,097,685

 

 

 

1,696,636

 

Income before taxes

 

591,513

 

 

 

731,737

 

 

 

241,502

 

 

 

748,064

 

Income tax (expense) benefit

 

(13,862

)

 

 

(29,875

)

 

 

5,654

 

 

 

(21,029

)

Net income

 

577,651

 

 

 

701,862

 

 

 

247,156

 

 

 

727,035

 

Net income attributable to redeemable noncontrolling interests

 

(113,544

)

 

 

(118,728

)

 

 

(66,694

)

 

 

(216,819

)

Net income available to RenaissanceRe

 

464,107

 

 

 

583,134

 

 

 

180,462

 

 

 

510,216

 

Dividends on preference shares

 

(7,289

)

 

 

(7,289

)

 

 

(14,578

)

 

 

(16,345

)

Net income available to RenaissanceRe common shareholders

$

456,818

 

 

$

575,845

 

 

$

165,884

 

 

$

493,871

 

 

 

 

 

 

 

 

 

Net income available to RenaissanceRe common shareholders per common share – basic

$

9.36

 

 

$

12.64

 

 

$

3.36

 

 

$

11.04

 

Net income available to RenaissanceRe common shareholders per common share – diluted

$

9.35

 

 

$

12.63

 

 

$

3.35

 

 

$

11.02

 

Operating income available to RenaissanceRe common shareholders per common share – diluted (1)

$

5.64

 

 

$

4.06

 

 

$

5.73

 

 

$

4.91

 

 

 

 

 

 

 

 

 

Average shares outstanding – basic

 

48,163

 

 

 

44,939

 

 

 

48,871

 

 

 

44,190

 

Average shares outstanding – diluted

 

48,226

 

 

 

45,003

 

 

 

48,940

 

 

 

44,253

 

 

 

 

 

 

 

 

 

Net claims and claim expense ratio

 

43.6

%

 

 

50.5

%

 

 

59.1

%

 

 

56.2

%

Underwriting expense ratio

 

28.8

%

 

 

28.0

%

 

 

28.4

%

 

 

29.2

%

Combined ratio

 

72.4

%

 

 

78.5

%

 

 

87.5

%

 

 

85.4

%

 

 

 

 

 

 

 

 

Return on average common equity – annualized

 

27.6

%

 

 

38.5

%

 

 

4.9

%

 

 

17.1

%

Operating return on average common equity – annualized (1)

 

16.8

%

 

 

12.7

%

 

 

8.4

%

 

 

7.8

%

(1)

 

See Comments on Regulation G for a reconciliation of non-GAAP financial measures.

RenaissanceRe Holdings Ltd.

Summary Consolidated Balance Sheets

(in thousands of United States Dollars, except per share amounts)

 

 

 

 

 

June 30,
2021

 

December 31,
2020

Assets

(Unaudited)

 

(Audited)

Fixed maturity investments trading, at fair value

$

13,418,389

 

 

$

13,506,503

 

Short term investments, at fair value

 

4,392,652

 

 

 

4,993,735

 

Equity investments trading, at fair value

 

577,090

 

 

 

702,617

 

Other investments, at fair value

 

1,585,036

 

 

 

1,256,948

 

Investments in other ventures, under equity method

 

91,938

 

 

 

98,373

 

Total investments

 

20,065,105

 

 

 

20,558,176

 

Cash and cash equivalents

 

1,789,756

 

 

 

1,736,813

 

Premiums receivable

 

4,481,492

 

 

 

2,894,631

 

Prepaid reinsurance premiums

 

1,361,041

 

 

 

823,582

 

Reinsurance recoverable

 

3,187,638

 

 

 

2,926,010

 

Accrued investment income

 

56,804

 

 

 

66,743

 

Deferred acquisition costs and value of business acquired

 

883,926

 

 

 

633,521

 

Receivable for investments sold

 

457,458

 

 

 

568,293

 

Other assets

 

196,959

 

 

 

363,170

 

Goodwill and other intangible assets

 

246,576

 

 

 

249,641

 

Total assets

$

32,726,755

 

 

$

30,820,580

 

Liabilities, Noncontrolling Interests and Shareholders’ Equity

 

 

 

Liabilities

 

 

 

Reserve for claims and claim expenses

$

10,944,742

 

 

$

10,381,138

 

Unearned premiums

 

4,284,260

 

 

 

2,763,599

 

Debt

 

1,137,304

 

 

 

1,136,265

 

Reinsurance balances payable

 

4,489,841

 

 

 

3,488,352

 

Payable for investments purchased

 

795,185

 

 

 

1,132,538

 

Other liabilities

 

201,398

 

 

 

970,121

 

Total liabilities

 

21,852,730

 

 

 

19,872,013

 

Redeemable noncontrolling interests

 

3,656,419

 

 

 

3,388,319

 

Shareholders’ Equity

 

 

 

Preference shares

 

525,000

 

 

 

525,000

 

Common shares

 

48,026

 

 

 

50,811

 

Additional paid-in capital

 

1,153,881

 

 

 

1,623,206

 

Accumulated other comprehensive loss

 

(14,061

)

 

 

(12,642

)

Retained earnings

 

5,504,760

 

 

 

5,373,873

 

Total shareholders’ equity attributable to RenaissanceRe

 

7,217,606

 

 

 

7,560,248

 

Total liabilities, noncontrolling interests and shareholders’ equity

$

32,726,755

 

 

$

30,820,580

 

 

 

 

 

Book value per common share

$

139.35

 

 

$

138.46

 

Contacts

INVESTORS:
RenaissanceRe Holdings Ltd.

Keith McCue

Senior Vice President, Finance & Investor Relations

(441) 239-4830

MEDIA:
RenaissanceRe Holdings Ltd.

Keil Gunther

Senior Vice President, Head of Global Marketing & Client Communication

(441) 239-4932

or

Kekst CNC

Dawn Dover

(212) 521-4800

Read full story here

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button